Peptide Therapeutics Market: Booming Revenue and Trend in 2021 Scrutinized in New Research 2023 | Says Kenneth Research

This post was originally published on this site

The MarketWatch News Department was not involved in the creation of this content.

May 04, 2021 (AmericaNewsHour) — Kenneth Research recently added a report on Peptide Therapeutics Market in its database of market research reports which provides its readers an in-depth analysis on the latest trends, growth opportunities and growth drivers that are associated with the growth of the market. The report additionally shares critical insights on Peptide Therapeutics Market, along with the compound growth rate (CAGR) of the market for a projected period between 2021 and 2023. The report also includes analysis of the market by utilizing different analytical tools, such as PESTEL analysis and Porter’s five forces analysis. These tools also provide an in-depth analysis on the micro and macro-environmental factors that are associated with the growth of the market during the forecast period.

The peptide therapeutics market has been segmented by application into cancer, cardiovascular, central nervous system, metabolic disorders, infection, hematological disorders, gastrointestinal disorders, respiratory disorders, acromegaly and other applications. Among these segments, the cancer segment is estimated to observe high growth in upcoming years. This can be attributed to rising number of cancer patients across the globe. Further, technical innovations and rise in research and development activities for new treatment and drugs are some of the factors that are anticipated to drive the growth of cancer segment in overall peptide therapeutics market with noteworthy revenue by the end of 2023. 

Download Sample of This Strategic Report-:
https://www.kennethresearch.com/sample-request-10075343

The global market of peptide therapeutics is anticipated to reach market valuation of USD 26.2 Billion by 2023 as compared to USD 15.6 Billion in 2015 by expanding at a significant compound annual growth rate of 8.2% over the period 2016-2023. Factors such as rising clinical drug researches in order to treat cancers and other disorders and introduction of advanced cost effective therapeutic peptides combined with their safety and effectiveness is anticipated to propel the growth of peptide therapeutics market in upcoming years.

“The Final Report will cover the impact analysis of COVID-19 on this industry.”

In the regional segment, North America accounted for USD 7.42 Billion in 2015 and is expected to continue its dominance in overall peptide therapeutics market across the globe by expanding at a compound annual growth rate of 6.9% over the period 2016-2023. This can be attributed to escalation of pharmaceutical and biotech companies across the region. Further, the presence of large number of biotech companies in Europe is estimated to make Europe as the second largest share contributor in peptide therapeutics market across the globe. Moreover, rising prevalence of cancer and nervous system disorders combined with increasing healthcare spending by the government establishments is anticipated to drive the demand for peptide therapeutics in Asia Pacific region.

Research Laboratories & Preference towards Peptide Therapeutics by Doctors to Boom the Market

Growing geriatric population is predicted to expand the demand for peptide therapeutics owing to prevalence of rising health diseases such as cardiac, cardiovascular and osteoporosis among others. Further, the rise is biotech companies and preference by physicians towards peptide therapeutics combined with cumulative demand in research laboratories to produce more effective drugs for the treatment of cancer is believed to supplement the growth of peptide therapeutics market across the globe.

However, increasing cost and presence of stringent regulatory controls for peptide therapeutics is likely to inhibit the growth of the peptide therapeutics market in the near future.

The report titled “Peptide Therapeutics Market: Global Market Size, Demand Analysis & Opportunity Outlook 2023” delivers detailed overview of the peptide therapeutics market in terms of market segmentation by application, by drugs type, by end-user and by region.

Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.

This report also provides the existing competitive scenario of some of the key players of the peptide therapeutics market which includes company profiling of Bachem Holding AG, CordenPharma International GmbH, Eli Lilly and Company, Ipsen S.A., Merck & Co., Novo Nordisk A/S and PolyPeptide Group.

The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the peptide therapeutics market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

“The Final Report will cover the impact analysis of COVID-19 on this industry.”

Download Sample of This Strategic Report-:
https://www.kennethresearch.com/sample-request-10075343

About Kenneth Research:

Kenneth Research provides market research reports to different individuals, industries, associations and organizations with an aim of helping them to take prominent decisions. Our research library comprises of more than 10,000 research reports provided by more than 15 market research publishers across different industries. Our collection of market research solutions covers both macro level as well as micro level categories with relevant and suitable market research titles. As a global market research reselling firm, Kenneth Research provides significant analysis on various markets with pure business intelligence and consulting services on different industries across the globe. In addition to that, our internal research team always keep a track on the international and domestic market for any economic changes impacting the products’ demand, growth and opportunities for new and existing players.

Contact Us

Kenneth Research

Email: Sales@kennethresearch.com

Phone: +1 313 462 0609

The post Peptide Therapeutics Market: Booming Revenue and Trend in 2021 Scrutinized in New Research 2023 | Says Kenneth Research appeared first on America News Hour.

COMTEX_385818840/2606/2021-05-04T07:14:51

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

The MarketWatch News Department was not involved in the creation of this content.